Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Current Alzheimer Research|June 14, 2018
Strategies for Continued Successful Treatment in Patients with Alzheimer's Disease: An Overview of Switching Between Pharmacological AgentsRafael Blesa, Kazuhiro Toriyama, Kengo Ueda, et al.
Expert Review of Neurotherapeutics|December 19, 2024
The impact of cognitive reserve relative to risk of Alzheimer's disease and rate of progression: an up-to-date review of the literatureJordan Beveridge, Poorva Sheth, Shaan Thakkar, et al.
Journal of Geriatric Psychiatry and Neurology|July 5, 2021
The Role of The Gut Microbiome in Parkinson's DiseaseAmy Gallop, James Weagley, Saif-Ur-Rahman Paracha, et al.
Expert Opinion on Emerging Drugs|January 9, 2024
How promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer's disease?Jordan Beveridge, Eileen Kaniecki, Aniketh Naidu, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 22, 2002
Impact of Alzheimer's disease and rivastigmine treatment on activities of daily living over the course of mild to moderately severe diseaseSteven G Potki, Ravi Anand, Richard Hartman, et al.
Clinics in Geriatric Medicine|November 19, 2021
Alcohol Use Disorder in Older AdultsGabriela Fenollal-Maldonado, Derek Brown, Heidi Hoffman, et al.
Journal of Geriatric Psychiatry and Neurology|October 1, 2024
Association Between Antipsychotic Medication Use and Dementia Risk in Patients With Schizophrenia or Schizoaffective DisorderKirti Veeramachaneni, Yuzhi Wang, George Grossberg, et al.
Current Medical Research and Opinion|September 11, 2010
The ACTION study: methodology of a trial to evaluate safety and efficacy of a higher dose rivastigmine transdermal patch in severe Alzheimer's diseaseMartin R Farlow, George Grossberg, Serge Gauthier, et al.
Expert Opinion on Pharmacotherapy|December 4, 2024
Recent advances in Alzheimer's disease therapy: clinical trials and literature review of novel enzyme inhibitors targeting amyloid precursor proteinDominic Antony, Poorva Sheth, Aaron Swenson, et al.
International Journal of Geriatric Psychiatry|February 20, 2014
Efficacy of higher-dose 13.3 mg/24 h (15 cm2) rivastigmine patch on the Alzheimer's Disease Assessment Scale-cognitive subscale: domain and individual item analysisGustavo Alva, Richard Isaacson, Carl Sadowsky, et al.
Pageof 4